Literature DB >> 11237085

Early diagnosis of dementia.

K S Santacruz1, D Swagerty.   

Abstract

Until recently, the most significant issue facing a family physician regarding the diagnosis and treatment of dementia was ruling out delirium and potentially treatable etiologies. However, as more treatment options become available, it will become increasingly important to diagnose dementia early. Dementia may be suspected if memory deficits are exhibited during the medical history and physical examination. Information from the patient's family members, friends and caregivers may also point to signs of dementia. Distinguishing among age-related cognitive decline, mild cognitive impairment and Alzheimer's disease may be difficult and requires evaluation of cognitive and functional status. Careful medical evaluation to exclude treatable causes of cognitive impairment is important. Patients with early dementia may benefit from formal neuropsychologic testing to aid in medical and social decision-making. Follow-up by the patient's family physician is appropriate in most patients. However, a subspecialist may be helpful in the diagnosis and management of patients with dementia with an unusual presentation or following an atypical course.

Entities:  

Mesh:

Year:  2001        PMID: 11237085

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  16 in total

1.  When help becomes a hindrance: mental health referral systems as barriers to care for primary care physicians treating patients with Alzheimer's disease.

Authors:  Carol E Franz; Judith C Barker; Kathleen Kim; Yvette Flores; Cecily Jenkins; Richard L Kravitz; Ladson Hinton
Journal:  Am J Geriatr Psychiatry       Date:  2010-07       Impact factor: 4.105

2.  Senile Dementia from Neuroscientific and Islamic Perspectives.

Authors:  Mohd Amzari Tumiran; Noor Naemah Abdul Rahman; Rohaida Mohd Saat; Ahmad Zuhdi Ismail; Wan Adriyani Wan Ruzali; Nurul Kabir Nurul Bashar; Durriyyah Sharifah Hasan Adli
Journal:  J Relig Health       Date:  2018-02

3.  Relationship of dementia screening tests with biomarkers of Alzheimer's disease.

Authors:  James E Galvin; Anne M Fagan; David M Holtzman; Mark A Mintun; John C Morris
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

Review 4.  Psychiatric presentations/manifestations of medical illnesses.

Authors:  Jack Castro; Stephen Billick
Journal:  Psychiatr Q       Date:  2013-09

5.  Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.

Authors:  Katie Skeehan; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

6.  Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.

Authors:  Tivadar Lucza; Kázmér Karádi; János Kállai; Rita Weintraut; József Janszky; Attila Makkos; Sámuel Komoly; Norbert Kovács
Journal:  Behav Neurol       Date:  2015-05-19       Impact factor: 3.342

7.  Detecting Dementia Through Interactive Computer Avatars.

Authors:  Hiroki Tanaka; Hiroyoshi Adachi; Norimichi Ukita; Manabu Ikeda; Hiroaki Kazui; Takashi Kudo; Satoshi Nakamura
Journal:  IEEE J Transl Eng Health Med       Date:  2017-09-15       Impact factor: 3.316

8.  Developing and testing a South African Brief Cognitive Score in literate and illiterate people of mixed language groups.

Authors:  Clara M Schutte; Mukhethwa Tsikane; Keorapetse Nchoe
Journal:  S Afr J Psychiatr       Date:  2021-05-27       Impact factor: 1.550

9.  Early Dementia Questionnaire (EDQ): a new screening instrument for early dementia in primary care practice.

Authors:  Zurraini Arabi; Noor Azah Aziz; Aznida Firzah Abdul Aziz; Rosdinom Razali; Sharifa Ezat Wan Puteh
Journal:  BMC Fam Pract       Date:  2013-04-16       Impact factor: 2.497

10.  The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.

Authors:  Elisabeth Kapaki; George P Paraskevas; Evangelia Emmanouilidou; Kostas Vekrellis
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.